Regulatory roadmap for biotechs: Effective strategies for streamlined early phase development

Are you an emerging or small biotech seeking to optimize the early phase development of your small molecule or biologic drug product? Join the webinar recording, available on demand that highlights important regulatory considerations that apply across the global landscape, and help accelerate your initial clinical trials.

In this webinar, our ex-agency expert panel discussed potential early phase challenges and offered strategic solutions to avoid or overcome them. 

What will you learn? 

  • Early-phase CMC strategies for biologics and small molecules
  • Essential non-clinical considerations for first-in-human (FIH) trials
  • Clinical and clinical pharmacology perspectives

Don't miss this opportunity to gain actionable insights that could advance your early phase development strategy and maximize opportunities for regulatory success.

Watch now

Return to Insights Center

Related Insights

Related Insights

Playbook

What emerging trends in the FDA’s most coveted designations might tell us

Feb 8, 2024

Blog

Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial

Nov 19, 2021

Blog

Proof of product safety and efficacy: how to move ahead successfully in Phase 2 clinical development

Jan 22, 2025

Blog

Overcoming risks in Phase 3 trials to accelerate time to market

Jan 22, 2025

Article

8 things you need to know about eCTDs in China

Jul 1, 2022

Video

Overcoming asset transfer challenges during a merger and acquisition (M&A)

Oct 20, 2021

Show more